Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 2/20 | 0.46 |
| ▸ | ITK | Q08881 | 2/20 | 0.46 |
| ▸ | AURKB | Q96GD4 | 2/20 | 0.46 |
| ▸ | MERTK | Q12866 | 8/20 | 0.41 |
| ▸ | AXL | P30530 | 6/20 | 0.41 |
| ▸ | BTK | Q06187 | 2/20 | 0.40 |
| ▸ | CHUK | O15111 | 1/20 | 0.38 |
| ▸ | TYRO3 | Q06418 | 6/20 | 0.38 |
| ▸ | MAPK14 | Q16539 | 5/20 | 0.38 |
| ▸ | GAS6 | Q14393 | 3/20 | 0.38 |
| ▸ | FLT3 | P36888 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5204412 | 1.00 | LCK (0.46) | LCKITKAURKBMERTKAXL | |
| SCHEMBL1379520 | 0.91 | LCK (0.43) | LCKITKAURKBMERTKAXL | |
| SCHEMBL1379519 | 0.91 | LCK (0.43) | LCKITKAURKBMERTKAXL | |
| SCHEMBL1379026 | 0.88 | MAPT (0.44) | LCKMERTKAXLBTKCHUK | |
| SCHEMBL1379676 | 0.88 | BTK (0.41) | LCKITKAURKBMERTKAXL | |
| SCHEMBL1376242 | 0.88 | BTK (0.40) | LCKITKAURKBMERTKAXL | |
| SCHEMBL1376243 | 0.88 | BTK (0.40) | LCKITKAURKBMERTKAXL | |
| SCHEMBL1379021 | 0.88 | MAPT (0.44) | LCKMERTKAXLBTKCHUK | |
| SCHEMBL5203150 | 0.88 | BTK (0.40) | LCKITKAURKBMERTKAXL | |
| SCHEMBL7157240 | 0.88 | BTK (0.39) | LCKITKAURKBMERTKAXL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1165523-B1 | NEUROTROPHIC SUBSTITUTED PYRIMIDINES | KRENITSKY PHARMACEUTICALS INC (US) | 2007-11-07 | — | — | EP | claimed |
| US-6583148-B1 | Neurodegenerative or other neurological disorders; enhancing the effect of nerve growth factor; 2-Amino-5-(4-chlorophenoxy)-4-trans-4-hydroxycyclohexylamino) pyrimidine | KRENITSKY PHARMACEUTICALS, INC. | 2003-06-24 | — | — | US | claimed |
| EP-1165523-B1 | NEUROTROPHIC SUBSTITUTED PYRIMIDINES | KRENITSKY PHARMACEUTICALS INC (US) | 2007-11-07 | — | — | EP | disclosed |
| US-6916820-B1 | Neurotrophic substituted pyrimidines | KRENITSKY PHARMACEUTICALS, INC. (US) | 2005-07-12 | — | — | US | disclosed |
| US-6583148-B1 | Neurodegenerative or other neurological disorders; enhancing the effect of nerve growth factor; 2-Amino-5-(4-chlorophenoxy)-4-trans-4-hydroxycyclohexylamino) pyrimidine | KRENITSKY PHARMACEUTICALS, INC. | 2003-06-24 | — | — | US | disclosed |